November 14, 2023 Comments Off on New patent for Alkermes Inc drug LYBALVI Posted in: Patent Added Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Alkermes Inc drug LYBALVI appeared first on DrugPaten…
November 14, 2023 Comments Off on New patent for Norton Waterford drug QVAR REDIHALER Posted in: Patent Added Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. It is available from three suppliers. There are twelve…
The post New patent for Norton Waterford drug QVAR REDIHALER app…